1.
ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER. WEJMMS [Internet]. 2024 Jun. 10 [cited 2024 Nov. 20];2(6):11-20. Available from: https://westerneuropeanstudies.com/index.php/3/article/view/1131